Segment disclosures

Company overview

CAREDX, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

28 dimension combinations 184 retained observations 27 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Patient And Digital Solutions · Reportable Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=cdna:PatientAndDigitalSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3019230000 USD20260730Open filing evidence
2026-01-01 – 2026-06-3035186000 USD20260730Open filing evidence
2026-01-01 – 2026-03-3115956000 USD20260428Open filing evidence
2025-01-01 – 2025-12-3156933000 USD20260225Open filing evidence
2025-07-01 – 2025-09-3015409000 USD20251104Open filing evidence
2025-01-01 – 2025-09-3040176000 USD20251104Open filing evidence
2025-04-01 – 2025-06-3012813000 USD20260730Open filing evidence
2025-01-01 – 2025-06-3024767000 USD20260730Open filing evidence
2025-01-01 – 2025-03-3111954000 USD20260428Open filing evidence
2024-01-01 – 2024-12-3143621000 USD20260225Open filing evidence
2024-07-01 – 2024-09-3011864000 USD20251104Open filing evidence
2024-01-01 – 2024-09-3032228000 USD20251104Open filing evidence
2024-04-01 – 2024-06-3010746000 USD20250806Open filing evidence
2024-01-01 – 2024-06-3020364000 USD20250806Open filing evidence
2024-01-01 – 2024-03-319618000 USD20250430Open filing evidence
2023-01-01 – 2023-12-3137122000 USD20260225Open filing evidence
2022-01-01 – 2022-12-3128794000 USD20250228Open filing evidence

Product · Reportable Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3012791000 USD20260730Open filing evidence
2026-01-01 – 2026-06-3023137000 USD20260730Open filing evidence
2026-01-01 – 2026-03-3110346000 USD20260428Open filing evidence
2025-01-01 – 2025-12-3148377000 USD20260225Open filing evidence
2025-07-01 – 2025-09-3012478000 USD20251104Open filing evidence
2025-01-01 – 2025-09-3035121000 USD20251104Open filing evidence
2025-04-01 – 2025-06-3011833000 USD20260730Open filing evidence
2025-01-01 – 2025-06-3022643000 USD20260730Open filing evidence
2025-01-01 – 2025-03-3110810000 USD20260428Open filing evidence
2024-01-01 – 2024-12-3140783000 USD20260225Open filing evidence
2024-07-01 – 2024-09-3010212000 USD20251104Open filing evidence
2024-01-01 – 2024-09-3029416000 USD20251104Open filing evidence
2024-04-01 – 2024-06-3010610000 USD20250806Open filing evidence
2024-01-01 – 2024-06-3019204000 USD20250806Open filing evidence
2024-01-01 – 2024-03-318594000 USD20250430Open filing evidence
2023-01-01 – 2023-12-3133517000 USD20260225Open filing evidence
2022-01-01 – 2022-12-3129251000 USD20250228Open filing evidence

Service · Reportable Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3099927000 USD20260730Open filing evidence
2026-01-01 – 2026-06-30191325000 USD20260730Open filing evidence
2026-01-01 – 2026-03-3191398000 USD20260428Open filing evidence
2025-01-01 – 2025-12-31274495000 USD20260225Open filing evidence
2025-07-01 – 2025-09-3072168000 USD20251104Open filing evidence
2025-01-01 – 2025-09-30196122000 USD20251104Open filing evidence
2025-04-01 – 2025-06-3062033000 USD20260730Open filing evidence
2025-01-01 – 2025-06-30123954000 USD20260730Open filing evidence
2025-01-01 – 2025-03-3161921000 USD20260428Open filing evidence
2024-01-01 – 2024-12-31249381000 USD20260225Open filing evidence
2024-07-01 – 2024-09-3060807000 USD20251104Open filing evidence
2024-01-01 – 2024-09-30185562000 USD20251104Open filing evidence
2024-04-01 – 2024-06-3070918000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30124755000 USD20250806Open filing evidence
2024-01-01 – 2024-03-3153837000 USD20250430Open filing evidence
2023-01-01 – 2023-12-31209685000 USD20260225Open filing evidence
2022-01-01 – 2022-12-31263748000 USD20250228Open filing evidence

Rest Of The World · Post Transplant

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=cdna:RestOfTheWorldMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember
PeriodValueUnitFiledEvidence
2018-04-01 – 2018-06-300 USD20180809Open filing evidence
2018-01-01 – 2018-06-300 USD20180809Open filing evidence
2017-04-01 – 2017-06-300 USD20180809Open filing evidence
2017-01-01 – 2017-06-300 USD20180809Open filing evidence

Rest Of The World · Pre Transplant

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=cdna:RestOfTheWorldMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember
PeriodValueUnitFiledEvidence
2018-04-01 – 2018-06-30276000 USD20180809Open filing evidence
2018-01-01 – 2018-06-30607000 USD20180809Open filing evidence
2017-04-01 – 2017-06-30405000 USD20180809Open filing evidence
2017-01-01 – 2017-06-30897000 USD20180809Open filing evidence

AU · Post Transplant

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:AU;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember
PeriodValueUnitFiledEvidence
2018-04-01 – 2018-06-300 USD20180809Open filing evidence
2018-01-01 – 2018-06-300 USD20180809Open filing evidence
2017-04-01 – 2017-06-300 USD20180809Open filing evidence
2017-01-01 – 2017-06-300 USD20180809Open filing evidence

AU · Pre Transplant

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:AU;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember
PeriodValueUnitFiledEvidence
2018-04-01 – 2018-06-3031000 USD20180809Open filing evidence
2018-01-01 – 2018-06-30105000 USD20180809Open filing evidence
2017-04-01 – 2017-06-30125000 USD20180809Open filing evidence
2017-01-01 – 2017-06-30241000 USD20180809Open filing evidence

Europe · Post Transplant

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember
PeriodValueUnitFiledEvidence
2018-04-01 – 2018-06-3024000 USD20180809Open filing evidence
2018-01-01 – 2018-06-3041000 USD20180809Open filing evidence
2017-04-01 – 2017-06-3023000 USD20180809Open filing evidence
2017-01-01 – 2017-06-3038000 USD20180809Open filing evidence

Europe · Pre Transplant

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember
PeriodValueUnitFiledEvidence
2018-04-01 – 2018-06-301856000 USD20180809Open filing evidence
2018-01-01 – 2018-06-303829000 USD20180809Open filing evidence
2017-04-01 – 2017-06-301863000 USD20180809Open filing evidence
2017-01-01 – 2017-06-303922000 USD20180809Open filing evidence

North America · Post Transplant

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember
PeriodValueUnitFiledEvidence
2018-04-01 – 2018-06-3014147000 USD20180809Open filing evidence
2018-01-01 – 2018-06-3024876000 USD20180809Open filing evidence
2017-04-01 – 2017-06-308647000 USD20180809Open filing evidence
2017-01-01 – 2017-06-3016549000 USD20180809Open filing evidence

North America · Pre Transplant

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember
PeriodValueUnitFiledEvidence
2018-04-01 – 2018-06-301489000 USD20180809Open filing evidence
2018-01-01 – 2018-06-302418000 USD20180809Open filing evidence
2017-04-01 – 2017-06-30983000 USD20180809Open filing evidence
2017-01-01 – 2017-06-301983000 USD20180809Open filing evidence

Allenex

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cdna:AllenexMember
PeriodValueUnitFiledEvidence
2016-04-01 – 2016-06-303475000 USD20160822Open filing evidence
2016-01-01 – 2016-06-303475000 USD20160822Open filing evidence
2015-04-01 – 2015-06-300 USD20160822Open filing evidence
2015-01-01 – 2015-06-300 USD20160822Open filing evidence

Care Dx

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cdna:CareDxMember
PeriodValueUnitFiledEvidence
2017-07-01 – 2017-09-308319000 USD20171109Open filing evidence
2017-01-01 – 2017-09-3024905000 USD20171109Open filing evidence
2017-04-01 – 2017-06-308670000 USD20170811Open filing evidence
2017-01-01 – 2017-06-3016587000 USD20170811Open filing evidence
2017-01-01 – 2017-03-317917000 USD20170609Open filing evidence
2016-01-01 – 2016-12-3129917000 USD20170421Open filing evidence
2016-07-01 – 2016-09-308721000 USD20171109Open filing evidence
2016-01-01 – 2016-09-3022543000 USD20171109Open filing evidence
2016-04-01 – 2016-06-307260000 USD20170811Open filing evidence
2016-01-01 – 2016-06-3013822000 USD20170811Open filing evidence
2016-01-01 – 2016-03-316562000 USD20170609Open filing evidence
2015-01-01 – 2015-12-3128144000 USD20170421Open filing evidence
2015-07-01 – 2015-09-307151000 USD20161115Open filing evidence
2015-01-01 – 2015-09-3021496000 USD20161115Open filing evidence
2015-04-01 – 2015-06-307129000 USD20160822Open filing evidence
2015-01-01 – 2015-06-3014344000 USD20160822Open filing evidence
2014-01-01 – 2014-12-3127306000 USD20170421Open filing evidence

Olerup

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cdna:OlerupMember
PeriodValueUnitFiledEvidence
2017-07-01 – 2017-09-303872000 USD20171109Open filing evidence
2017-01-01 – 2017-09-3010916000 USD20171109Open filing evidence
2017-04-01 – 2017-06-303376000 USD20170811Open filing evidence
2017-01-01 – 2017-06-307043000 USD20170811Open filing evidence
2017-01-01 – 2017-03-313667000 USD20170609Open filing evidence
2016-01-01 – 2016-12-3110714000 USD20170421Open filing evidence
2016-07-01 – 2016-09-303754000 USD20171109Open filing evidence
2016-01-01 – 2016-09-307228000 USD20171109Open filing evidence
2016-04-01 – 2016-06-303475000 USD20170811Open filing evidence
2016-01-01 – 2016-06-303475000 USD20170811Open filing evidence
2016-01-01 – 2016-03-310 USD20170609Open filing evidence
2015-01-01 – 2015-12-310 USD20170421Open filing evidence
2015-07-01 – 2015-09-300 USD20161115Open filing evidence
2015-01-01 – 2015-09-300 USD20161115Open filing evidence
2014-01-01 – 2014-12-310 USD20170421Open filing evidence

Post Transplant

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember
PeriodValueUnitFiledEvidence
2018-04-01 – 2018-06-3014171000 USD20180809Open filing evidence
2018-01-01 – 2018-06-3024917000 USD20180809Open filing evidence
2018-01-01 – 2018-03-3110746000 USD20180510Open filing evidence
2017-01-01 – 2017-12-3133690000 USD20180322Open filing evidence
2017-04-01 – 2017-06-308670000 USD20180809Open filing evidence
2017-01-01 – 2017-06-3016587000 USD20180809Open filing evidence
2017-01-01 – 2017-03-317917000 USD20180510Open filing evidence
2016-01-01 – 2016-12-3129916000 USD20180322Open filing evidence
2015-01-01 – 2015-12-3128144000 USD20180322Open filing evidence

Pre Transplant

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember
PeriodValueUnitFiledEvidence
2018-04-01 – 2018-06-303652000 USD20180809Open filing evidence
2018-01-01 – 2018-06-306959000 USD20180809Open filing evidence
2018-01-01 – 2018-03-313307000 USD20180510Open filing evidence
2017-01-01 – 2017-12-3114634000 USD20180322Open filing evidence
2017-04-01 – 2017-06-303376000 USD20180809Open filing evidence
2017-01-01 – 2017-06-307043000 USD20180809Open filing evidence
2017-01-01 – 2017-03-313667000 USD20180510Open filing evidence
2016-01-01 – 2016-12-3110715000 USD20180322Open filing evidence
2015-01-01 – 2015-12-310 USD20180322Open filing evidence

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30139362000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2026-01-01 – 2026-09-30389010000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2026-04-01 – 2026-06-30131948000 USD20260730Open filing evidence
2026-01-01 – 2026-06-30249648000 USD20260730Open filing evidence
2026-01-01 – 2026-03-31117700000 USD20260428Open filing evidence
2025-01-01 – 2025-12-31379805000 USD20260225Open filing evidence
2025-07-01 – 2025-09-30100055000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2025-01-01 – 2025-09-30271419000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2025-04-01 – 2025-06-3086679000 USD20260730Open filing evidence
2025-01-01 – 2025-06-30171364000 USD20260730Open filing evidence
2025-01-01 – 2025-03-3184685000 USD20260428Open filing evidence
2024-01-01 – 2024-12-31333785000 USD20260225Open filing evidence
2024-07-01 – 2024-09-3082883000 USD20251104Open filing evidence
2024-01-01 – 2024-09-30247206000 USD20251104Open filing evidence
2024-04-01 – 2024-06-3092274000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30164323000 USD20250806Open filing evidence
2024-01-01 – 2024-03-3172049000 USD20250430Open filing evidence
2023-01-01 – 2023-12-31280324000 USD20260225Open filing evidence
2022-01-01 – 2022-12-31321793000 USD20250228Open filing evidence

Reportable Segment · Patient And Digital Solutions

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember;srt:ProductOrServiceAxis=cdna:PatientAndDigitalSolutionsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3020171000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2026-01-01 – 2026-09-3055357000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2025-07-01 – 2025-09-3015409000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2025-01-01 – 2025-09-3040176000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence

Reportable Segment · Product

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2026-01-01 – 2026-09-3023137000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2025-07-01 – 2025-09-3012478000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2025-01-01 – 2025-09-3035121000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence

Reportable Segment · Service

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cdna:ReportableSegmentMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30119191000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2026-01-01 – 2026-09-30310516000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2025-07-01 – 2025-09-3072168000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence
2025-01-01 – 2025-09-30196122000 USD2026-10-29 · 20:04:25.000ZOpen filing evidence

Rest Of The World · Post Transplant

Statement Geographical · Statement Business Segments

Source dimensions us-gaap:StatementGeographicalAxis=cdna:RestOfTheWorldMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-310 USD20180510Open filing evidence
2017-01-01 – 2017-03-310 USD20180510Open filing evidence

Rest Of The World · Pre Transplant

Statement Geographical · Statement Business Segments

Source dimensions us-gaap:StatementGeographicalAxis=cdna:RestOfTheWorldMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-31331000 USD20180510Open filing evidence
2017-01-01 – 2017-03-31492000 USD20180510Open filing evidence

AU · Post Transplant

Statement Geographical · Statement Business Segments

Source dimensions us-gaap:StatementGeographicalAxis=country:AU;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-310 USD20180510Open filing evidence
2017-01-01 – 2017-03-310 USD20180510Open filing evidence

AU · Pre Transplant

Statement Geographical · Statement Business Segments

Source dimensions us-gaap:StatementGeographicalAxis=country:AU;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-3174000 USD20180510Open filing evidence
2017-01-01 – 2017-03-31116000 USD20180510Open filing evidence

Europe · Post Transplant

Statement Geographical · Statement Business Segments

Source dimensions us-gaap:StatementGeographicalAxis=us-gaap:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-3117000 USD20180510Open filing evidence
2017-01-01 – 2017-03-3115000 USD20180510Open filing evidence

Europe · Pre Transplant

Statement Geographical · Statement Business Segments

Source dimensions us-gaap:StatementGeographicalAxis=us-gaap:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-311973000 USD20180510Open filing evidence
2017-01-01 – 2017-03-312059000 USD20180510Open filing evidence

North America · Post Transplant

Statement Geographical · Statement Business Segments

Source dimensions us-gaap:StatementGeographicalAxis=us-gaap:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PostTransplantMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-3110729000 USD20180510Open filing evidence
2017-01-01 – 2017-03-317902000 USD20180510Open filing evidence

North America · Pre Transplant

Statement Geographical · Statement Business Segments

Source dimensions us-gaap:StatementGeographicalAxis=us-gaap:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=cdna:PreTransplantMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-31929000 USD20180510Open filing evidence
2017-01-01 – 2017-03-311000000 USD20180510Open filing evidence